Jefferies analyst David Windley upgrades Medpace Hldgs (NASDAQ:MEDP) from Hold to Buy and raises the price target from $340 to $450.
Jefferies Upgrades Medpace Hldgs to Buy, Raises Price Target to $450
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.